The article presents parameters for obtaining a carbon dioxide extract from the subterranean part of Eryngium planum that contains a valuable set of organic substances and has a certain antimicrobial effect. Methods. Raw materials were collected in the Almaty region (Republic of Kazakhstan). The CO2 extract of Eryngium planum herbs was obtained under subcritical conditions. A gas chromatograph with a mass spectrometric detector was used to determine the compositional breakdown of the extract. Antimicrobial activity was determined by two methods: the micromethod of serial dilutions and the disk-diffusion method. Three microbial test strains were used: Staphylococcus aureus ATCC 6538-P, Escherichia coli ATCC 8739, and Candida albicans ATCC 10231. Results. To extract biologically active substances from the subterranean part of Eryngium planum L., we have chosen carbon dioxide extraction technology, a technology for processing carbon dioxide (CO2) raw materials, which allows us to extract various substances in high concentrations. Carbon dioxide extraction technology is an effective and environmentally safe way to isolate various biologically active substances contained in medicinal plant raw materials. In the composition of the CO2 extract of Eryngium planum L. 43 components were identified, the main of which are α-linolenic acid, 8.30; myristic acid, 6.40; caryophyllene, 6.92; spatulous, 6.62; and other main identified compounds and their percentage. Conclusions. The study showed that the CO2 extract of Eryngium planum L. contains biologically active compounds that have a pronounced antimicrobial effect against clinically significant microorganisms, such as Escherichia coli, Staphylococcus aureus, and Candida albicans.
27 October 2023 in Drug development & registration
Разработка технологии получения фитосубстанции расторопши пятнистой плодов ( Silybum marianum L.) в качестве компонента комплексной терапии заболеваний печени
To optimize the process of pharmaceutical development, it is necessary to take into account the timeframes of the processes and to track all its key stages. To do this, it is necessary to create an algorithm for conducting research, taking into account the modern approach to pharmaceutical development the concept of Quality by Design. The aim of this work was to create an algorithm of actions in conducting research when developing a new drug that can be used in the production process. Flowcharts were used for depicting algorithms. To account the timeframes of the processes, a Gantt diagram was used. The process of pharmaceutical development when launching a new generic drug has been studied at an operating pharmaceutical company. An algorithm for the actions of staff involved in research is proposed The algorithm minds the concept of Quality by Design. A temporary Gannta scheme and a project manager's control card for the process of pharmaceutical development of a generic drug have been developed. Based on the results of the work, an algorithm of actions in conducting research when developing a new drug that can be used in the production process was proposed.
Transfer of technologies is a logical, controllable and documented procedure of transfer of technology and control methods of medicine from the developer to the producer or from one producer to another [1]. A lot of departments of the enterprise involved in this process, their organization and coordination of work determines the character, timeliness and completeness of the transfer that has a direct influence on the quality of products. The task of the company in transfer of technologies is to preserve the quality of products and compliance with GxP rules, while material resources, time and space of the enterprise are economizing. Transfer of technologies divides into a preparatory stage and two main stages. The universal algorithm of the project of transfer of technology for the introducing a new drug at the operating enterprise is developed, the system of the organization of control and risk assessment of project activity is defined.
24 December 2021 in Drug development & registration
Introduction. Substances of plant origin exhibit a variety of pharmacological activity in combination with a relatively low toxicity and frequency of side effects. In this regard, a promising direction is the standardization of substances of plant origin in the development of new herbal medicinal products.Aim. Qualitative and quantitative determination of individual coumarin in a dry extract of Melilotus оfficinalis L.Materials and methods. A dry extract of the Melilotus officinalis L. was used as an object of research. Determination of individual coumarin was carried out by high-performance liquid chromatography.Results and discussion. As a result of the research, coumarin was identified by high performance liquid chromatography based on comparison of retention times of the sample with retention times of a standard sample of coumarin in the sample of dry extract under research. The coumarin contents in the dry extract was 0.642 ± 0.007 %.Conclusion. The data obtained on the qualitative and quantitative content of coumarin in the dry extract of Melilotus оfficinalis L. were used in the development of the draft version specification of quality indicators.